Showing 8,041 - 8,060 results of 37,850 for search '(( 50 ((ng decrease) OR (((we decrease) OR (a decrease)))) ) OR ( 10 mg decrease ))', query time: 1.01s Refine Results
  1. 8041
  2. 8042

    Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 Diabetes by Bruce A. Perkins (312635)

    Published 2015
    “…Trends toward lower glycemic variability (83.1±18.9 to 75.6±28.6mg/dL, p = 0.06) and little change in glycemic stability (10.8±3.6 to 10.3±4.5mg/dL/h, p = 0.51) were observed. …”
  3. 8043

    Discovery of Novel 3‑Phenylpiperidine Derivatives Targeting the β‑Catenin/B-Cell Lymphoma 9 Interaction as a Single Agent and in Combination with the Anti-PD‑1 Antibody for the Tre... by Hao Zhang (15339)

    Published 2023
    “…Among them, compound <b>41</b> showed the best IC<sub>50</sub> (0.72 μM) in a competitive fluorescence polarization assay and a <i>K</i><sub>D</sub> value of 0.26 μM for the β-catenin protein. …”
  4. 8044

    Discovery of Novel 3‑Phenylpiperidine Derivatives Targeting the β‑Catenin/B-Cell Lymphoma 9 Interaction as a Single Agent and in Combination with the Anti-PD‑1 Antibody for the Tre... by Hao Zhang (15339)

    Published 2023
    “…Among them, compound <b>41</b> showed the best IC<sub>50</sub> (0.72 μM) in a competitive fluorescence polarization assay and a <i>K</i><sub>D</sub> value of 0.26 μM for the β-catenin protein. …”
  5. 8045

    Discovery of Novel 3‑Phenylpiperidine Derivatives Targeting the β‑Catenin/B-Cell Lymphoma 9 Interaction as a Single Agent and in Combination with the Anti-PD‑1 Antibody for the Tre... by Hao Zhang (15339)

    Published 2023
    “…Among them, compound <b>41</b> showed the best IC<sub>50</sub> (0.72 μM) in a competitive fluorescence polarization assay and a <i>K</i><sub>D</sub> value of 0.26 μM for the β-catenin protein. …”
  6. 8046

    Discovery of Novel 3‑Phenylpiperidine Derivatives Targeting the β‑Catenin/B-Cell Lymphoma 9 Interaction as a Single Agent and in Combination with the Anti-PD‑1 Antibody for the Tre... by Hao Zhang (15339)

    Published 2023
    “…Among them, compound <b>41</b> showed the best IC<sub>50</sub> (0.72 μM) in a competitive fluorescence polarization assay and a <i>K</i><sub>D</sub> value of 0.26 μM for the β-catenin protein. …”
  7. 8047
  8. 8048
  9. 8049
  10. 8050
  11. 8051
  12. 8052
  13. 8053

    Intraperitoneal administration with streptavidin benefits an establishment of a CD-1 mice model for <i>P</i>. <i>aeruginosa</i>, of which the plasma (and organ contents) biotin lev... by Yu Shi (117923)

    Published 2023
    “…<i>aeruginosa</i>, the model of CD-1 mice is subjected for an intraperitoneal administration with streptavidin (2 mg/kg) as recently Carfrae <i>et al</i>. [<a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1011110#ppat.1011110.ref015" target="_blank">15</a>] recommended, which is supposed to reduce the biotin levels in mouse plasma and other organ contents. …”
  14. 8054

    Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP<sub>2</sub> by Shunda Yang (8086265)

    Published 2022
    “…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”
  15. 8055

    Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP<sub>2</sub> by Shunda Yang (8086265)

    Published 2022
    “…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”
  16. 8056

    Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP<sub>2</sub> by Shunda Yang (8086265)

    Published 2022
    “…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”
  17. 8057

    Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP<sub>2</sub> by Shunda Yang (8086265)

    Published 2022
    “…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”
  18. 8058

    Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP<sub>2</sub> by Shunda Yang (8086265)

    Published 2022
    “…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”
  19. 8059

    Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP<sub>2</sub> by Shunda Yang (8086265)

    Published 2022
    “…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”
  20. 8060

    Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP<sub>2</sub> by Shunda Yang (8086265)

    Published 2022
    “…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”